Peptide synthesis gives researchers direct access to precisely designed amino acid sequences that may be difficult to obtain from natural sources or recombinant expression systems. By controlling sequence, length, terminal groups, side-chain functionality, stereochemistry, and post-synthetic modifications, scientists can prepare peptides for biochemical research, drug discovery programs, structure-activity relationship studies, assay development, and analytical reference work. In modern peptide development, the central question is rarely whether a peptide can be made by chemical synthesis; it is which synthetic strategy can deliver the desired sequence with acceptable purity, yield, scalability, and project efficiency.
Solid phase peptide synthesis (SPPS) and liquid phase peptide synthesis (LPPS) represent two major approaches for chemical peptide assembly. SPPS is widely used because stepwise synthesis on an insoluble resin simplifies repetitive coupling and washing operations. LPPS, in contrast, builds peptides in solution and allows closer control over soluble intermediates, making it valuable for selected short peptides, peptide fragments, and convergent synthetic routes. For complex peptide development, SPPS and LPPS are not opposing choices; they can be combined strategically to solve sequence-specific challenges and improve the overall synthesis plan.
BOC Sciences provides integrated peptide synthesis support for research teams seeking reliable custom peptide preparation, route selection, purification, and analytical confirmation. Our scientists evaluate sequence complexity, intended research use, modification pattern, and downstream analysis needs to design a synthesis workflow that balances chemical feasibility with practical project execution.
Peptide synthesis is the controlled formation of peptide bonds between amino acids to create a defined peptide sequence. Each amino acid contains an amino group, a carboxyl group, and a side chain that may require protection during synthesis. To avoid uncontrolled branching or side reactions, peptide chemists use protecting groups to mask reactive sites, activate the carboxyl component for amide bond formation, and then remove temporary protection at the appropriate stage. Through repeated cycles of coupling and deprotection, a target peptide chain is assembled in a planned direction, usually from the C-terminus toward the N-terminus in SPPS. Chemical peptide synthesis is highly flexible because it is not limited to the twenty common proteinogenic amino acids. It can incorporate D-amino acids, non-natural residues, terminal modifications, fluorescent labels, lipid chains, linkers, stable isotope labels, cyclic structures, and conjugation handles. This flexibility makes peptide synthesis particularly useful when researchers need to explore structure-function relationships, prepare analog panels, generate assay controls, or obtain modified peptides that are challenging to produce biologically.
Synthetic peptides are widely used in drug discovery and biochemical research because they connect molecular design with experimental testing. A peptide can mimic a protein motif, block an interaction interface, serve as an enzyme substrate, act as a binding probe, or provide a defined reference material for analytical studies. Since the sequence is chemically controlled, researchers can introduce systematic changes residue by residue and evaluate how charge, hydrophobicity, conformation, or modification affects biological recognition in in vitro experiments. Peptides also occupy a valuable design space between small molecules and larger biomolecules. They can present multiple functional groups in a compact structure, engage extended binding surfaces, and be tailored through cyclization, stapling, N-methylation, lipidation, PEGylation, glycosylation, or other modifications. In discovery-stage research, synthetic peptide libraries enable rapid screening of motif variants, while individual custom peptides support mechanism studies, binding assays, enzymology, immunochemical research, and mass spectrometry method development.
Successful peptide synthesis depends on more than sequence length. A short sequence may be difficult if it is highly hydrophobic, aggregation-prone, rich in beta-sheet-forming residues, or contains sterically demanding amino acids. A longer sequence may be manageable when the residues are soluble, well protected, and compatible with efficient coupling chemistry. Therefore, synthesis planning begins with a sequence feasibility review rather than a simple amino acid count. Important factors include the number of residues, distribution of charged and hydrophobic amino acids, presence of cysteine, methionine, tryptophan, aspartimide-prone motifs, N-terminal glutamine, C-terminal functionality, desired modifications, and final purity requirements. The required batch size also matters. A milligram-scale exploratory peptide may be approached differently from a larger research batch requiring repeat preparation. Analytical expectations, including mass confirmation, HPLC purity, impurity profiling, and structural characterization, should be considered before synthesis begins so that the purification and reporting workflow matches the project goal.
Solid phase peptide synthesis assembles the peptide chain on an insoluble polymeric resin. The first amino acid is attached to the resin through a linker that determines the final C-terminal functionality and cleavage behavior. After each coupling reaction, excess reagents and soluble by-products are removed by washing the resin. The next temporary protecting group is then removed, and the cycle repeats until the full sequence is complete. Finally, the peptide is cleaved from the resin and side-chain protecting groups are removed. The principal advantage of SPPS is operational efficiency. Since the growing peptide remains bound to the solid support, purification after every coupling step is usually not required. This makes SPPS highly suitable for parallel synthesis, sequence libraries, modified peptides, and many medium-length custom peptides. However, resin swelling, steric hindrance, incomplete coupling, aggregation, and difficult deprotection can reduce yield or purity, especially for long or hydrophobic sequences.
Liquid phase peptide synthesis constructs peptides in solution. Reactants and intermediates are soluble, allowing homogeneous reaction conditions and direct monitoring of intermediate quality. After each step or selected steps, intermediates can be isolated and purified before further elongation. LPPS can be valuable for short peptides, high-purity fragments, and cases where intermediate characterization is important. LPPS may involve linear elongation in solution or a convergent strategy in which protected peptide fragments are synthesized, purified, and then coupled. Because intermediates can be isolated, LPPS provides strong control over fragment identity and impurity removal. At the same time, repeated solution-phase purification can increase workload and material loss, so LPPS is most attractive when its control advantages outweigh the additional handling requirements.
A hybrid strategy combines the high-throughput convenience of SPPS with the intermediate control of LPPS. For example, shorter fragments may be prepared by SPPS, cleaved with side-chain protection retained when appropriate, purified, and then coupled in solution. This convergent route can reduce the number of sequential solid-phase steps required for a long peptide and may help manage aggregation, low resin accessibility, or sequence-dependent yield loss. Hybrid synthesis is especially useful when a peptide contains a difficult central region, multiple modifications, a macrocyclic motif, or a fragment that benefits from separate purification before final assembly. The decision depends on protecting group compatibility, solubility of fragments, coupling site selection, risk of racemization, and the analytical strategy for confirming each intermediate.
The following comparison summarizes how SPPS and LPPS are typically evaluated during route planning. In practice, the best method is determined by sequence behavior, desired scale, and required analytical confidence rather than by a single universal rule.
Table.1 Comparison of SPPS and LPPS for Peptide Development.
| Approach | Best-Fit Peptides | Strengths | Limitations |
| SPPS | Custom research peptides, libraries, modified peptides, many medium-length sequences | Efficient repetitive cycles, easy washing, compatible with automation, strong flexibility | Aggregation, incomplete coupling, resin-dependent accessibility, challenging long hydrophobic sequences |
| LPPS | Short peptides, purified fragments, selected solution-stable intermediates | Homogeneous reactions, intermediate isolation, flexible fragment quality control | More purification steps, greater handling complexity, potentially lower throughput |
| Hybrid SPPS/LPPS | Longer peptides, difficult sequences, cyclic or modified structures, fragment-based designs | Balances operational efficiency with fragment control and convergent assembly | Requires careful protecting group, solubility, and fragment coupling design |
Resin selection is one of the first decisions in SPPS. The resin must provide appropriate swelling in the chosen solvent system, sufficient loading capacity, mechanical stability, and compatibility with the linker and protecting group strategy. Common resin supports are designed to present reactive sites that anchor the C-terminal amino acid or a preloaded linker-amino acid unit. The linker determines whether cleavage yields a peptide acid, amide, or other C-terminal format. Resin loading affects both yield and synthesis quality. High loading can increase theoretical output but may also intensify steric crowding and aggregation as the chain grows. Lower loading often improves accessibility for difficult or hydrophobic sequences. For peptides expected to form secondary structure on resin, a lower-loading resin, PEG-containing support, or modified backbone protection strategy may improve coupling efficiency.
SPPS commonly uses Fmoc or Boc temporary N-terminal protection. Fmoc chemistry uses base-labile protection, typically removed under mild basic conditions, while side-chain protecting groups and resin linkers are selected to remain stable during repeated Fmoc removal. Boc chemistry uses acid-labile N-terminal protection and has different cleavage and side-chain deprotection requirements. Fmoc-based SPPS is widely used for many research peptide projects because it avoids repeated strong acid treatment during chain assembly and is compatible with many modern synthetic workflows. Side-chain protecting groups are chosen according to amino acid functionality and final deprotection conditions. For example, hydroxyl, thiol, carboxyl, guanidino, imidazole, and indole groups may require protection to avoid side reactions during activation and coupling. Orthogonal protection can also be used when a side-chain modification, cyclization, or selective conjugation must occur before global deprotection.
The core SPPS cycle includes deprotection of the N-terminus, washing, coupling of the next protected amino acid, and another washing step. Coupling reagents activate the incoming amino acid carboxyl group so it can react with the resin-bound amine. Reagent choice, equivalents, coupling time, solvent, temperature, and base all influence conversion and side reaction risk. Difficult couplings may require double coupling, extended reaction time, stronger activation conditions, microwave-assisted heating, or alternative amino acid derivatives. However, stronger conditions are not always better. Overactivation can increase racemization or side reactions, especially at sensitive residues. A well-designed SPPS method balances conversion with chemical selectivity.
After sequence assembly, the peptide is cleaved from the resin and side-chain protecting groups are removed. Cleavage conditions depend on the resin linker and protecting group system. In Fmoc SPPS, acid-mediated cleavage is commonly used to release the peptide and remove side-chain protections. Scavengers are often included to capture reactive species generated during cleavage and reduce undesired modifications. Cleavage is a chemically sensitive stage because the full peptide is exposed to conditions that can affect residues such as cysteine, methionine, tryptophan, asparagine, glutamine, and acid-sensitive modifications. Reaction time, acid composition, scavenger selection, precipitation conditions, and post-cleavage handling must be optimized to recover the desired crude peptide while minimizing degradation and side-product formation.
Crude peptide mixtures may contain deletion sequences, truncated products, side-reaction products, protecting group remnants, oxidized forms, diastereomers, and closely related impurities. Purification is therefore a critical part of peptide synthesis rather than a separate afterthought. Reversed-phase HPLC is commonly used because it can separate peptides based on hydrophobicity and subtle structural differences. Ion-exchange, size-exclusion, or other separation modes may be selected for specific peptide properties. Analytical characterization confirms that the purified material matches the intended design. LC-MS can verify molecular weight and reveal impurity patterns, while HPLC provides purity information. For more complex structures, additional characterization may be used to support sequence identity, modification location, cyclization status, or conformational interpretation.
A typical SPPS workflow begins with sequence evaluation and resin selection. The C-terminal residue is anchored to the resin, followed by a series of N-terminal deprotection and amino acid coupling cycles. After the final residue is added, the N-terminus may be left free or modified by acetylation, labeling, lipidation, or another group. The peptide is then cleaved, precipitated or recovered, dissolved under suitable conditions, purified, analyzed, and lyophilized. The workflow can be summarized as follows: sequence review, resin and linker selection, protecting group strategy, resin swelling, first deprotection, repeated coupling/deprotection cycles, optional on-resin modification, cleavage and global deprotection, crude recovery, preparative purification, analytical confirmation, and final drying. Each stage offers opportunities for optimization when the peptide shows poor coupling, low solubility, broad HPLC peaks, unexpected mass shifts, or multiple closely eluting impurities.
Fig.1 SPPS LPPS workflow for peptide development.
LPPS forms peptide bonds in a homogeneous solution environment. Protected amino acids or peptide fragments are dissolved with coupling reagents and bases under conditions designed to promote amide bond formation while minimizing epimerization. Since the growing peptide is not immobilized on a resin, reaction progress can be monitored through conventional solution-phase analytical methods, and intermediates can be isolated when needed. Solution-phase conditions can improve contact between reacting species and may avoid mass-transfer limitations encountered in swollen resin systems. However, the growing peptide must remain sufficiently soluble throughout the process. Solubility challenges can become significant as peptide length increases, especially for hydrophobic sequences or fragments with strong self-association tendencies.
Protecting group design is especially important in LPPS because each intermediate may be isolated, purified, stored, and later used in another coupling reaction. Temporary N-terminal protection, side-chain protection, and C-terminal protection must be compatible with the planned sequence of reactions. Orthogonal protecting groups allow selective deprotection of one functional group while keeping others masked. Good LPPS design considers not only reactivity but also solubility and purification behavior. A protected fragment that is chemically correct but poorly soluble may be difficult to use in the next step. Similarly, protecting groups can influence chromatographic separation, crystallization tendency, and fragment coupling efficiency. For this reason, LPPS planning often integrates route design with purification strategy from the beginning.
One of the main advantages of LPPS is the ability to isolate and purify intermediates. This feature allows researchers to remove deletion products, excess reagents, and side-products before further elongation. For short peptides and fragments, intermediate isolation can improve confidence that the next coupling step starts from a well-defined material. Intermediate purification can be performed by precipitation, extraction, crystallization, chromatography, or combinations of these methods, depending on peptide size and chemical properties. While this control is valuable, it can also reduce material throughput if every step requires extensive purification. Efficient LPPS therefore relies on selecting purification checkpoints strategically rather than purifying unnecessarily after every minor transformation.
Fragment coupling is a powerful use of LPPS. Instead of adding one amino acid at a time to a growing sequence, defined protected peptide fragments are assembled separately and then joined. This convergent approach can reduce the number of linear steps, improve overall material quality, and provide better control over difficult regions of the sequence. Fragment coupling requires careful selection of the coupling junction. Sites with low racemization risk, favorable solubility, and minimal steric hindrance are preferred. The fragments should also have compatible protecting groups and terminal functionalities. In some cases, SPPS is used to prepare fragments efficiently, while LPPS is used for final fragment condensation.
A practical LPPS workflow begins with defining the target peptide or fragment and selecting protected amino acid building blocks. The first coupling forms a protected dipeptide or short intermediate. After workup and purification, selective deprotection reveals the next reactive site. The process repeats until the protected peptide or fragment reaches the desired length. Final deprotection, purification, and analytical confirmation then provide the target peptide. For fragment-based synthesis, the workflow includes fragment boundary selection, separate fragment preparation, purification of each fragment, coupling of protected fragments, final deprotection, and polishing purification. Analytical checkpoints are often placed after fragment preparation and final assembly to ensure that structural errors do not accumulate.
LPPS offers homogeneous reaction conditions, direct intermediate analysis, flexible purification checkpoints, and strong control over fragment quality. It can be especially useful for short peptides, high-value intermediates, and convergent strategies that reduce the burden of long linear SPPS. LPPS may also be preferred when a specific intermediate needs to be isolated for characterization or when resin-bound synthesis gives poor performance. Limitations include increased handling, solubility dependence, purification workload, and potentially lower throughput for routine sequence libraries. Longer peptides may become difficult to maintain in solution, and repeated purification can reduce overall recovery. Therefore, LPPS is often most effective when used selectively for sequences or fragments that benefit from solution-phase control.
Sequence length is a useful starting point but not the only factor. SPPS is efficient for many short and medium-length peptides because repetitive cycles can be performed without isolating each intermediate. As peptide length increases, the probability of deletion sequences and incomplete reactions also increases, and the route may require special coupling protocols or fragment strategies. LPPS may be attractive for short peptides or protected fragments where intermediate purification improves confidence. For longer structures, a hybrid approach may divide the sequence into manageable fragments and reduce the number of consecutive difficult steps. The best route is often the one that minimizes cumulative chemical risk while preserving practical productivity.
Hydrophobic and aggregation-prone sequences are among the most common peptide synthesis challenges. During SPPS, growing chains can associate on resin, reducing accessibility of the terminal amine and causing incomplete coupling or deprotection. Sequences rich in valine, isoleucine, leucine, phenylalanine, alanine, or beta-sheet-forming motifs may show difficult behavior, although exact outcomes depend on the full sequence context. Strategies include using lower-loading resin, pseudoproline dipeptides, backbone-protecting groups, stronger swelling solvents, longer coupling times, double coupling, capping, or fragment-based synthesis. For highly hydrophobic fragments, LPPS may or may not improve the situation, depending on solubility. Careful solvent screening and route redesign can be more effective than simply changing the synthesis platform.
Modified peptides require additional route planning because functional groups must be introduced without damaging the peptide or interfering with later steps. Common modifications include N-terminal acetylation, C-terminal amidation, phosphorylation, methylation, glycosylation, lipidation, fluorescent labeling, biotinylation, PEGylation, and stable isotope incorporation. Some modifications can be introduced through premodified amino acid building blocks, while others are installed after chain assembly. Cyclic peptides and conjugated peptides often require orthogonal protecting groups that allow selective reaction at defined positions. SPPS can provide efficient access to linear precursors, while on-resin or solution-phase cyclization may be selected based on ring size, sequence flexibility, solubility, and side-reaction risk. LPPS can support fragment coupling or final conjugation when solution control is advantageous.
Peptide purity requirements should be defined early because they influence both synthesis and purification decisions. A peptide intended for preliminary screening may require a different purification level from a peptide used as an analytical reference or mechanistic probe. Higher purity targets often require more extensive preparative HPLC, additional polishing runs, and careful fraction selection. Yield and purity must be considered together. A route that provides high crude yield but produces many closely related impurities may be less efficient than a route with lower crude yield but easier purification. Analytical methods such as HPLC and LC-MS help identify whether impurities arise from deletion, oxidation, deamidation, aspartimide formation, racemization, incomplete deprotection, or cleavage-related side reactions.
Small exploratory batches emphasize speed, flexibility, and sequence feasibility. SPPS is well suited for this setting because resin-bound synthesis can rapidly generate multiple sequences or analogs. As scale increases, reagent consumption, solvent use, resin loading, mixing efficiency, crude purity, and purification capacity become more important. Larger research batches may require route optimization to improve reproducibility and reduce purification burden. LPPS or hybrid fragment coupling may be considered when intermediate isolation improves process control or when linear SPPS becomes inefficient. The route should be selected based on repeatability, material recovery, impurity profile, and ability to generate consistent analytical results.
Cost is influenced by amino acid building blocks, protecting groups, resin, coupling reagents, solvents, purification workload, analytical testing, and repeated optimization. SPPS can be efficient for routine custom synthesis but may consume excess reagents to drive resin-bound reactions to completion. LPPS may use fewer equivalents in some cases but can require more purification and handling. Process efficiency is therefore project-specific. For straightforward research peptides, SPPS often provides the most practical balance. For selected fragments or difficult sequences, LPPS or hybrid synthesis may reduce downstream problems and improve overall project value. A rational decision compares total workflow performance rather than the apparent cost of a single coupling step.
Table.2 Method Selection Guide for Peptide Synthesis Projects.
| Project Requirement | Recommended Strategy | Rationale |
| Short peptide with simple sequence | SPPS or LPPS | Both approaches may be feasible; selection depends on scale, purity target, and intermediate control needs. |
| Medium-length custom research peptide | SPPS | Efficient cycle-based assembly and straightforward washing support rapid preparation. |
| Long or aggregation-prone sequence | Optimized SPPS or hybrid SPPS/LPPS | Lower-loading resin, special building blocks, or fragment coupling may reduce sequence-dependent failure. |
| High-purity protected fragment | LPPS or hybrid strategy | Intermediate isolation and purification can improve fragment quality before final assembly. |
| Cyclic or conjugated peptide | SPPS with orthogonal chemistry; optional solution-phase cyclization or conjugation | Linear precursor preparation can be combined with selective post-assembly reactions. |
Share your peptide sequence, modification requirements, and target scale with BOC Sciences for a customized synthesis strategy.
Bioactive peptides are designed to interact with enzymes, receptors, transporters, protein domains, nucleic acids, membranes, or other biological targets. Synthetic access allows researchers to build analogs that test how individual residues contribute to binding, activity, selectivity, or stability in in vitro assays. By modifying charge, hydrophobicity, terminal groups, or conformational constraints, scientists can explore how sequence features control molecular recognition.
Peptide libraries accelerate structure-activity relationship studies by providing a panel of related sequences for comparative testing. A library may scan alanine substitutions, conserved motifs, truncations, scrambled controls, D-amino acid replacements, or focused residue variations. SPPS is particularly valuable for library preparation because parallel cycle-based synthesis can generate multiple analogs using related conditions.
Modified peptides help researchers investigate phosphorylation-dependent binding, protease recognition, methylation effects, glycosylation-related interactions, lipid-mediated localization, and other molecular mechanisms. Chemical synthesis supports site-specific placement of modifications, enabling cleaner interpretation than heterogeneous biological mixtures. When modification chemistry is sensitive, the synthetic route must be planned to protect labile groups and avoid incompatible cleavage or purification conditions.
Peptide conjugates are used to attach peptides to fluorophores, biotin, linkers, polymers, lipids, nanoparticles, or other functional partners. Such conjugates can support imaging studies, binding assays, immobilization, pulldown experiments, delivery research, and materials-related peptide applications. Selective conjugation usually requires a defined handle, such as a cysteine thiol, lysine amine, azide, alkyne, or other orthogonal functional group.
Synthetic reference peptides support LC-MS method development, impurity identification, sequence confirmation, and comparative analytical studies. A reference peptide with known mass, purity, and sequence can help confirm retention time, fragmentation behavior, or impurity identity. For complex peptide projects, reference materials may include truncated sequences, modified analogs, oxidized forms, or specific stereochemical variants prepared for research comparison.
Incomplete coupling occurs when the incoming amino acid does not fully react with the resin-bound or solution-phase amine. Incomplete deprotection occurs when the temporary protecting group is not fully removed before the next coupling. Both problems generate deletion sequences or mixed products that can be difficult to separate from the desired peptide. Practical solutions include monitoring reaction completion, using double coupling for difficult residues, optimizing activation chemistry, adjusting solvent and swelling conditions, extending deprotection time when appropriate, and applying capping steps to block unreacted amines. For persistent problems, route redesign or fragment synthesis may be more effective than repeated forcing conditions.
Aggregation during SPPS can reduce reagent access to the growing chain and cause poor coupling, broad crude profiles, and low final recovery. Aggregation is often linked to hydrophobic stretches, hydrogen bonding, beta-sheet formation, or high local chain density on resin. The problem may appear suddenly after a certain residue is added, making early cycles look successful while later cycles deteriorate. Solutions include lower resin loading, different resin supports, stronger swelling solvents, pseudoproline or backbone-protected dipeptides, chaotropic additives, longer coupling times, microwave-assisted conditions, and fragment-based strategies. The goal is to disrupt chain-chain association and maintain accessibility of the reactive terminus.
Racemization can occur during activation of amino acids or fragments, producing diastereomeric impurities that may be difficult to detect and separate. Side reactions may include aspartimide formation, oxidation, diketopiperazine formation, N-terminal cyclization, protecting group migration, alkylation, and cleavage-related modifications. Sensitive residues and motifs should be identified before synthesis begins. Practical solutions include selecting low-racemization coupling reagents, using preactivated conditions carefully, reducing activation time for sensitive residues, choosing suitable bases, protecting vulnerable side chains, and avoiding unnecessarily harsh cleavage conditions. For fragment coupling, the coupling junction should be chosen to minimize epimerization risk.
Low solubility can interfere with cleavage workup, purification, analytical injection, lyophilization, and final formulation for research use. Hydrophobic peptides may precipitate in aqueous mobile phases, bind strongly to chromatographic surfaces, or show broad peaks. Highly basic or acidic peptides may require adjusted pH and ion-pairing conditions for workable HPLC separation. Strategies include screening dissolution solvents, using acetonitrile-water mixtures, adding small amounts of acid or base when compatible, selecting appropriate HPLC gradients, changing column chemistry, or modifying the peptide design with solubilizing residues or terminal groups when scientifically acceptable. For very difficult peptides, purification strategy should be developed in parallel with synthesis.
Peptide synthesis yield is cumulative. Even modest inefficiency at multiple steps can dramatically reduce final output. Yield loss may come from incomplete reactions, resin losses, cleavage inefficiency, precipitation problems, purification losses, or instability during handling. Because each sequence behaves differently, yield prediction remains challenging. A practical response is to identify where material is lost. If crude mass is low, the problem may be synthesis or cleavage. If crude mass is acceptable but purified recovery is poor, the issue may be solubility, HPLC resolution, or impurity overlap. Data-driven troubleshooting helps avoid repeating a failing workflow without understanding the root cause.
Analytical ambiguity arises when impurities have similar masses, when isobaric modifications occur, when multiple charge states complicate mass spectra, or when closely related peptides co-elute. Oxidation, deamidation, deletion sequences, and stereochemical variants can produce subtle differences that require careful method design. LC-MS, LC-MS/MS, HPLC purity analysis, and orthogonal separation methods can help clarify identity and purity. For cyclic or heavily modified peptides, additional characterization may be needed to confirm modification location, disulfide connectivity, or ring closure. Analytical planning should reflect the complexity of the peptide rather than relying on a single readout.
BOC Sciences offers custom peptide synthesis solutions covering sequence feasibility review, SPPS route design, LPPS and fragment-based support, modified peptide preparation, purification, and analytical characterization. Our workflow is designed for research teams that need reliable peptide materials supported by clear technical communication and project-specific synthesis planning.
Every project begins with sequence assessment. BOC Sciences reviews length, amino acid composition, hydrophobicity, charge distribution, aggregation risk, cysteine pattern, planned modifications, terminal groups, and target purity. This evaluation helps determine whether a standard SPPS route is suitable or whether special building blocks, orthogonal protection, fragment coupling, or customized purification should be considered.
BOC Sciences provides peptide synthesis services using SPPS-based strategies for a wide variety of research peptides. Depending on the project, our team can design resin selection, Fmoc or Boc chemistry, coupling protocols, N-terminal or C-terminal modifications, cleavage conditions, and purification workflows to support efficient peptide preparation.
For short peptides, protected intermediates, and difficult sequences requiring convergent assembly, BOC Sciences can develop LPPS or hybrid SPPS/LPPS strategies. Fragment-based planning may reduce the number of consecutive linear steps and allow intermediate purification before final coupling. This approach is particularly useful when sequence complexity or modification placement makes a conventional linear route less efficient.
BOC Sciences supports the preparation of modified peptides, cyclic peptides, and peptide conjugates for research applications. Available project types may include terminal modifications, disulfide-containing peptides, side-chain cyclization, macrocyclic peptide design, labeled peptides, biotinylated peptides, lipidated peptides, PEGylated peptides, and peptides containing non-natural amino acids. For conjugation projects, selective handles and orthogonal reaction conditions are selected to preserve sequence integrity.
Purification and characterization are integrated into the synthesis plan. Preparative HPLC, analytical HPLC, LC-MS, LC-MS/MS, purity determination, and structure characterization can be used according to the peptide design and project requirements. Final reports may include sequence information, molecular weight confirmation, chromatographic purity, purification conditions, and relevant analytical observations.
Table.3 Custom Peptide Synthesis and Analytical Support Services at BOC Sciences.
| Service Name | Description | Inquiry |
| Oligopeptide Synthesis | Preparation of short peptide sequences and oligopeptide materials for biochemical research, assay design, and sequence-activity studies. | Inquiry |
| Macrocyclic Peptides Synthesis | Design and synthesis support for macrocyclic peptide structures requiring cyclization strategy, orthogonal protection, and analytical confirmation. | Inquiry |
| Peptide Conjugation Service | Selective peptide conjugation with functional tags, linkers, labels, or other research molecules using project-specific reaction design. | Inquiry |
| Preparative HPLC | Preparative purification of crude peptides and peptide-related materials to support purity improvement and fraction collection. | Inquiry |
| LC-MS Testing | Molecular weight confirmation and impurity observation for synthetic peptides, modified peptides, and peptide fragments. | Inquiry |
| Structure Characterization | Integrated analytical support for confirming peptide identity, modification status, and structural features in complex peptide projects. | Inquiry |
| Purity Determination | Chromatographic purity assessment for synthetic peptides, peptide fragments, and purified peptide research materials. | Inquiry |
Connect with BOC Sciences to discuss your peptide sequence, SPPS or LPPS route options, purification target, and analytical characterization requirements.
Reference
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
